Event provides the opportunity for students and researchers to learn more about the important aging and dementia research taking place at Northwestern.
Dimitri Krainc, MD, PhD, a distinguished investigator of international stature whose research has had a transformative impact in the area of neurodegenerative diseases, will join Northwestern University Feinberg School of Medicine on July 1 as Aaron Montgomery Ward Professor, chair of the Ken and Ruth Davee Department of Neurology, and director of the newly established…
One of only a handful of centers focused on women of all ages who may be suffering from reproductive-related depression, the Asher Center for the Study and Treatment of Depressive Disorders will integrate state-of-the art research into clinical care to make sure that women with depression receive the care that they need.
William Grobman, MD, MBA, professor in obstetrics and gynecology-maternal fetal medicine, reviewed data from 115,502 women over a three year period and determined that race and ethnicity affect obstetric care and outcomes.
Having dedicated her career to investigating how bones are developed and the mechanisms that cause their deterioration, Paula Stern, PhD, recently published an article on vitamin D and its effect on osteoperosis.
In a new preclinical study, a Northwestern Medicine® scientist has isolated the motor neurons in the brain that die in ALS and, for the first time, dressed them in a green fluorescent jacket. As a result, scientists will now be able to track what goes wrong in these cells to cause their deaths and be…
Third-year medical students Alexander Sheu and Patrick Tyler received awards at the Society of Interventional Radiology Annual Scientific Meeting for their research in the field. This interest led them to start a student group to promote research opportunities and mentoring in the specialty.
A Northwestern Medicine® and University of Alabama study published recently in the European Heart Journal found no evidence that digoxin increases mortality in patients with atrial fibrillation (AF), the opposite of results just published by another group in the same journal analyzing the same data.
Within the next few decades, getting a new kidney could be as simple as having a doctor order an engineered organ that will be developed in the laboratory with a patient’s own cells. Delivery could take a few months and, theoretically, a patient might not need immunosuppressant drugs because his body would recognize the kidney…
With the help of genetics, prostate specific antigen (PSA) screenings may become more accurate and reduce the number of unnecessary prostate biopsies.